erucov-vac
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 5, 2020 (NCT04691947)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04824391 | Phase 2 | Feb 10, 2021 | Erciyes University, Government of Turkey, Organicell Regenerative Medicine, Inc |
| NCT04691947 | Phase 1 | Nov 5, 2020 | Erciyes University, Government of Turkey |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Erciyes University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Government of Turkey | Government | 2 | 2 | 2 | 2020 |
| Organicell Regenerative Medicine, Inc | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1